Inventisbio Co.,Ltd.
益方生物
Inventisbio Co.,Ltd.
Biotech/Healthcare
InventisBio (Yifang Biotech (Shanghai) Co., Ltd.) is a clinical-stage biopharmaceutical company dedicated to developing first-in-class and best-in-class innovative drugs with independent intellectual property, targeting major diseases such as cancer and metabolic disorders.
Latest round: IPO (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.